Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection

Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies

(2014) M.I. Biondo et al.   European Journal of Internal Medicine

Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy

(2014) Mauro Viganò et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Systemic diseases and biotherapies: Understanding, evaluating, and preventing the risk of hepatitis B reactivation

(2014) Françoise Lunel-Fabiani et al.   JOINT BONE SPINE

Prevalence of reactivation of hepatitis B virus replication in rheumatoid arthritis patients

(2014) Yukitomo Urata et al.   Modern Rheumatology

Treatment of rheumatic diseases and hepatitis B virus coinfection

(2014) Anna Felis-Giemza et al.   RHEUMATOLOGY INTERNATIONAL

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012: Table 1

(2013) Daniel E Furst et al.   ANNALS OF THE RHEUMATIC DISEASES

Effects of costimulation on intrahepatic immunopathogenesis in patients with chronic HBV infection

(2013) Bei Zhong et al.   INFLAMMATION RESEARCH

Association between cytotoxic T-lymphocyte associated protein 4 gene +49 A/G polymorphism and chronic infection with hepatitis B virus: A meta-analysis

(2013) Hangdi Xu et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection

(2013) A. Fanouriakis et al.   RHEUMATOLOGY

Immunosuppression and HBV Reactivation

(2013) Oren Shibolet et al.   SEMINARS IN LIVER DISEASE

Kinetic Profiles and Management of Hepatitis B Virus Reactivation in Patients With Immune-Mediated Inflammatory Diseases

(2013) Nina Droz et al.   ARTHRITIS CARE & RESEARCH

Prevention and Management of Infectious Complications in IBD

(2012) Jean-François Rahier   DIGESTIVE DISEASES

Abatacept therapy and safety management

(2012) Thao Pham et al.   JOINT BONE SPINE

Patients with hematological malignancies and serological signs of prior resolved hepatitis B

(2012) Massimo Marignani   World Journal of Gastrointestinal Oncology

Let the fog be lifted: screening for hepatitis B virus before biological therapy

(2011) K. L. Winthrop et al.   ANNALS OF THE RHEUMATIC DISEASES

The impact of biologic response modifiers on hepatitis B virus infection

(2011) Matthew B Carroll   EXPERT OPINION ON BIOLOGICAL THERAPY

Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management

(2011) Mauro Viganò et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection

(2011) Anna Schurich et al.   HEPATOLOGY

TNF alpha antagonist therapy and safety monitoring

(2011) Thao Pham et al.   JOINT BONE SPINE

Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts

(2011) Akihiro Tamori et al.   JOURNAL OF GASTROENTEROLOGY

Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept

(2011) Georgios Germanidis et al.   JOURNAL OF HEPATOLOGY

Hepatitis B Virus Reactivation by Immunosuppressive Therapy in Patients with Autoimmune Diseases: Risk Analysis in Hepatitis B Surface Antigen-negative Cases

(2011) MASARU KATO et al.   JOURNAL OF RHEUMATOLOGY

Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy

(2011) Roberto Pérez-Alvarez et al.   MEDICINE

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2010) S. van Assen et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety of tumor necrosis factor α blockers in hepatitis B virus occult carriers (hepatitis B surface antigen negative/anti-hepatitis B core antigen positive) with rheumatic diseases

(2010) R. Caporali et al.   ARTHRITIS CARE & RESEARCH

Management of adult patients with ascites due to cirrhosis: An update

(2009) Bruce A. Runyon   HEPATOLOGY

Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients

(2009) Caroline Charpin et al.   ARTHRITIS RESEARCH & THERAPY

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

(2008) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction

(2007) Patricia M. Davis et al.   CLINICAL IMMUNOLOGY